收藏本站
收藏 | 手机打开
二维码
手机客户端打开本文

Development and validation of a nomogram for predicting the probability of death within 3 months in patients with advanced pancreatic ductal adenocarcinoma

Shu Dong  Chenchen Wang  Chenyue Zhang  Lei Wang  Haifeng Ying  Xiaoheng Shen  Yuanbiao Guo  Yehua Shen  Hao Chen  Qinglong Deng  Yaxuan Zhang  Jinming Yu  Zhiqiang Meng  Zhaoshen Li  Qiwen Chen  
【摘要】:Background: The prognosis of advanced pancreatic ductal adenocarcinoma(PDAC) is diverse among different patients. Therefore a vehicle to assess its prognosis is of great clinical significance. The study aimed to construct and validate a nomogram to predict the probability of death within 3 months in patients with advanced PDAC. Methods: The nomogram was based on a prospective multicenter cohort study involving 1,526 advanced PDAC patients from three participating hospitals in China. Two thirds of the patients were randomly assigned to the training set(n=1,017), and one third were assigned to the validation set(n=509). Multivariate logistic regression analysis was performed to identify factors associated with death within 3 months to develop the nomogram. Internal and external validation using C-index and calibration curve were conducted in the training set and validation set respectively. Results: Eight independent factors(gender, age, smoking, tumor stage, ALT, ALB, CA19-9, HBV infection status) as identified by multivariate logistic model were entered into the nomogram. The calibration curves for predicting probability of death within 3 months showed satisfactory accordance between nomogram prediction and actual observation. The C-indexes of the proposed nomogram were 0.822 in the training set and 0.841 in the validation set. Conclusions: The proposed nomogram can serve as an effective tool for predicting the probability of death within 3 months in patients with advanced PDAC.

知网文化
【相似文献】
中国期刊全文数据库 前20条
1 Chandra Diwakarla;Katherine Hannan;Nadine Hein;Desmond Yip;;Advanced pancreatic ductal adenocarcinoma-Complexities of treatment and emerging therapeutic options[J];World Journal of Gastroenterology;2017年13期
2 Hui-Lin Ye;Dou-Dou Li;Qing Lin;Yu Zhou;Quan-Bo Zhou;Bing Zeng;Zhi-Qiang Fu;Wen-Chao Gao;Yi-Min Liu;Rui-Wan Chen;Zhi-Hua Li;Ru-Fu Chen;;Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival[J];World Journal of Gastroenterology;2015年21期
3 ;Pancreas[J];China Medical Abstracts(Internal Medicine);2012年02期
4 Samuel J Tingle;John A Moir;Steven A White;;Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma[J];World Journal of Gastrointestinal Pathophysiology;2015年04期
5 ;Expression and signifi cance of TLR4 and HIF-1α in pancreatic ductal adenocarcinoma[J];World Journal of Gastroenterology;2010年23期
6 Claudia Di Carlo;Jessica Brandi;Daniela Cecconi;;Pancreatic cancer stem cells:Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma[J];World Journal of Stem Cells;2018年11期
7 Sirio Fiorino;;HBV and HCV infection and pancreatic ductal adenocarcinoma[J];Hepatobiliary & Pancreatic Diseases International;2013年06期
8 Irene Esposito;Bj?rn Konukiewitz;Anna Melissa Schlitter;Günter Kl?ppel;;Pathology of pancreatic ductal adenocarcinoma:Facts,challenges and future developments[J];World Journal of Gastroenterology;2014年38期
9 Daniel ?kerberg;Daniel Ansari;Roland Andersson;;Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas[J];World Journal of Gastroenterology;2016年28期
10 Rajkumar Krishnasamy;Shaleen Agarwal;Shivendra Singh;Sunil Puri;Puja Sakhuja;Anil K Agarwal;;Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia:report of a case[J];Hepatobiliary & Pancreatic Diseases International;2007年05期
11 Jianlin Chen;Yunmian Chu;Jin He;Lei Zheng;Xu Che;;Precision medicine in the treatment of pancreatic ductal adenocarcinoma[J];Oncology and Translational Medicine;2016年04期
12 Christian Pilarsky;Robert Grützmann;;Genomics of pancreatic ductal adenocarcinoma[J];Hepatobiliary & Pancreatic Diseases International;2014年04期
13 Norihiro Sato;Xiao-Bo Cheng;Shiro Kohi;Atsuhiro Koga;Keiji Hirata;;Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma[J];Acta Pharmaceutica Sinica B;2016年02期
14 Stephan Kruger;Michael Haas;Steffen Ormanns;Sibylle Bchmann;Jens T Siveke;Thomas Kirchner;Volker Heinemann;Stefan Boeck;;Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts[J];World Journal of Gastroenterology;2014年31期
15 Mirko Muroni;Francesco D'Angelo;Massimo Pezzatini;Simone Sebastiani;Samantha Noto;Emanuela Pilozzi;Giovanni Ramacciato;;Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma[J];Hepatobiliary & Pancreatic Diseases International;2010年01期
16 Anil K Agarwal;;Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia(The Author reply)[J];Hepatobiliary & Pancreatic Diseases International;2008年02期
17 Jawad Ahmad;Nathan Grimes;Shahid Farid;Gareth Morris-Stiff;;Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma:a systematic review[J];Hepatobiliary & Pancreatic Diseases International;2014年05期
18 Run-Fen Cheng;Jian Wang;Jing-Yi Zhang;Lin Sun;Yan-Rui Zhao;Zhi-Qiang Qiu;Bao-Cun Sun;Yan Sun;;MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression[J];Chinese Journal of Cancer;2016年12期
19 Tantan Liu;Yingmei Wang;Ru Zhou;Haiyang Li;Hong Cheng;Jing Zhang;;The update of prostatic ductal adenocarcinoma[J];Chinese Journal of Cancer Research;2016年01期
20 Garvi J Pandya;Vishal G Shelat;;Radiofrequency ablation of pancreatic ductal adenocarcinoma:The past,the present and the future[J];World Journal of Gastrointestinal Oncology;2015年02期
中国重要会议论文全文数据库 前10条
1 Shu Dong;Chenchen Wang;Chenyue Zhang;Lei Wang;Haifeng Ying;Xiaoheng Shen;Yuanbiao Guo;Yehua Shen;Hao Chen;Qinglong Deng;Yaxuan Zhang;Jinming Yu;Zhiqiang Meng;Zhaoshen Li;Qiwen Chen;;Development and validation of a nomogram for predicting the probability of death within 3 months in patients with advanced pancreatic ductal adenocarcinoma[A];第十七届全国中西医结合肿瘤学术大会摘要集[C];2019年
2 崔亚洲;田美;宗美娟;陈彧;刘骁勇;韩金祥;;Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma[A];华东六省一市生物化学与分子生物学会2008年学术交流会论文摘要汇编[C];2008年
3 Zihao GUO;Jie ZHANG;Yan LIANG;Xue LI;Jing CHEN;Jian-yu HAO;;Clinical study of EUS-FNA combining gene expression in pancreatic cancer diagnosis[A];2012中国消化系疾病学术大会论文汇编[C];2012年
4 hanshengxia;limingliu;qingyu;xiwang;qinglu;wenpingwang;;Papillomas with atypia or ductal carcinoma in situ:sonographic features and differentiation from benign papillomas of the breast[A];中华医学会第十三次全国超声医学学术会议论文汇编[C];2013年
5 Nan Zhang;Di Gao;Qian Shen;Yirun Wang;Yudan Liu;沙磊;;Substance P Promotes Proliferation of Adult Pancreatic Ductal Cells[A];中国生理学会内分泌代谢、比较生理与应激生理学术会议论文摘要汇编[C];2017年
6 Yuyan Wang;Hua Bai;Tongtong An;Jun Zhao;Jianchun Duan;Zhijie Wang;Minglei Zhuo;Shuhang Wang;Meina Wu;Jie Wang;;Original article Analysis of EGFR Mutation in Tissue coupled with Plasma for predicting response to EGFR-TKIs for Advanced Non-Small-Cell Lung Cancer[A];第13届全国肺癌学术大会论文汇编[C];2013年
7 Jia Deng;Lihua Liu;;Expression of serum long non-coding RNA NEAT 1 in lung adenocarcinoma and its clinical significance[A];第十三届全国免疫学学术大会摘要汇编[C];2018年
8 Ping Xu;Mengyang Zhao;Weiyi Fang;;Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients[A];第八次全国中西医结合变态反应学术会议暨首届深圳市中西医结合变态反应学术会议暨第十届深圳呼吸论坛论文汇编[C];2016年
9 任成龙;;Dual Energy Spectral CT for Assessing malignant grade between pure and partically invasive types of lung adenocarcinoma,Based on IASLC/ATS/ERS classification[A];中国中西医结合学会医学影像专业委员会第十五次全国学术大会暨上海市中西医结合学会医学影像专业委员会2017年学术年会暨《医学影像新技术的临床应用》国家级继续教育学习班资料汇编[C];2017年
10 许仙花;李君哲;赵荷;陈孟川;郑少江;;Wnt7A is a putative radiosensitivity marker in lung adenocarcinoma[A];第十一届全国免疫学学术大会摘要汇编[C];2016年
中国硕士学位论文全文数据库 前1条
1 王晓琳;乳腺癌中浸润淋巴细胞及细胞因子与临床病理特征和预后的关系[D];河北医科大学;2016年
 快捷付款方式  订购知网充值卡  订购热线  帮助中心
  • 400-819-9993
  • 010-62982499
  • 010-62783978